103.85
price up icon0.74%   0.76
after-market Dopo l'orario di chiusura: 101.53 -2.32 -2.23%
loading

Novartis Ag Adr Borsa (NVS) Ultime notizie

pulisher
10:17 AM

Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline - Benzinga

10:17 AM
pulisher
Nov 20, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 20, 2024
pulisher
Nov 20, 2024

Inside the Market Dominance of the Top 10 Pharma Giants - Value the Markets

Nov 20, 2024
pulisher
Nov 06, 2024

Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo Finance

Nov 06, 2024
pulisher
Nov 01, 2024

Our commitment to ethical and responsible use of Artificial Intelligence (AI) - Novartis

Nov 01, 2024
pulisher
Oct 29, 2024

Novartis on Pace for Largest Percent Decrease Since March 2021 — Data Talk - Morningstar

Oct 29, 2024
pulisher
Oct 29, 2024

Novartis Ag (NVS) Q3 2024 Earnings Call Transcript - Barchart

Oct 29, 2024
pulisher
Oct 29, 2024

Chemical Biology in Biomedical Research - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Radioligand therapy: delivering now, building for the future - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Novartis at ASH - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Novartis 2022 Financial Results - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Novartis Financial Results – Q2 2023 - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Translational medicine research at Novartis - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Novartis Financial Results – Q2 2024 - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Inclusivity - Novartis

Oct 29, 2024
pulisher
Oct 29, 2024

Collaborations - Novartis

Oct 29, 2024
pulisher
Oct 25, 2024

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Oct 25, 2024
pulisher
Oct 23, 2024

South Africa Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research

Oct 23, 2024
pulisher
Oct 22, 2024

5 Large Drug Stocks Likely To Outpace Q3 Earnings Estimates - Barchart

Oct 22, 2024
pulisher
Oct 21, 2024

Germany Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research

Oct 21, 2024
pulisher
Oct 18, 2024

21 Best Healthcare Companies to Invest In - Morningstar

Oct 18, 2024
pulisher
Oct 17, 2024

1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move - sharewise

Oct 17, 2024
pulisher
Oct 16, 2024

Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - GlobeNewswire Inc.

Oct 16, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 14, 2024

Roche Wins FDA Nod For Breast Cancer Drug In First-Line Setting - Barchart

Oct 14, 2024
pulisher
Oct 11, 2024

Denmark Basal Cell Carcinoma Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 11, 2024
pulisher
Oct 09, 2024

Europe Pruritus Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 09, 2024
pulisher
Oct 09, 2024

Norway Aspergillosis Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 09, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, Pipeline, Medication, Therapies, Treatment Market and Companies by DelveInsight - Barchart

Oct 03, 2024
pulisher
Oct 01, 2024

NVS: 3 European Stocks to Watch as the EU Economy Strengthens - StockNews.com

Oct 01, 2024
pulisher
Sep 25, 2024

Novartis Holds a Strong Branded Drug Portfolio Supporting Steady Long-term Growth - Morningstar

Sep 25, 2024
pulisher
Sep 21, 2024

Europe Alzheimers Therapeutics Market Size & Outlook, 2030 - Grand View Research

Sep 21, 2024
pulisher
Sep 20, 2024

Australia Alzheimers Therapeutics Market Size & Outlook, 2030 - Grand View Research

Sep 20, 2024
pulisher
Sep 18, 2024

Novartis Wins FDA Approval Of Kisqali For Early Breast Cancer - Barchart

Sep 18, 2024
pulisher
Sep 17, 2024

Novartis' Kisqali Lowers Risk Of Breast Cancer Recurrence By 28% - Barchart

Sep 17, 2024
pulisher
Sep 17, 2024

North America Immune Health Supplements Market Size & Outlook, 2030 - Grand View Research

Sep 17, 2024
pulisher
Sep 12, 2024

Top investors say Novartis AG ADR (NVS) ticks everything they need - SETE News

Sep 12, 2024
pulisher
Sep 11, 2024

Novartis lower as BofA downgrades on risks to valuation - MSN

Sep 11, 2024
drug_manufacturers_general MRK
$99.86
price up icon 2.48%
$289.90
price up icon 0.71%
drug_manufacturers_general PFE
$25.13
price up icon 0.76%
drug_manufacturers_general SNY
$47.98
price up icon 0.42%
drug_manufacturers_general BMY
$58.23
price up icon 0.60%
Capitalizzazione:     |  Volume (24 ore):